NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Registry fields
- Overall status
- ENROLLING_BY_INVITATION
- Conditions
- Systemic Lupus Erythematosus
- Study type
- INTERVENTIONAL
- Phase
- PHASE3
- Primary purpose
- TREATMENT
- Intervention type
- DRUG
- Interventions
- Dapirolizumab pegol
- Lead sponsor
- UCB Biopharma SRL (INDUSTRY)
Cached at: 2026-10-03 08:59:54
Brief summary
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
Contact
Need a report or Korean medical writing based on this trial?
Sign in with Kakao to continue